Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat in Myelodysplastic Syndromes
NCT00357162Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belinostat in myelodysplastic syndrome (MDS), sponsored by National Cancer Institute. Started May 2006; status: completed.
02
Drugs
belinostat
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00357162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357162.